Nan Fung Trinity (Hk) LTD Abeona Therapeutics Inc. Put Options Transaction History
Nan Fung Trinity (Hk) LTD
- $811 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding ABEO
# of Institutions
103Shares Held
31.5MCall Options Held
2.42MPut Options Held
212K-
Nantahala Capital Management, LLC New Canaan, CT4.37MShares$23.9 Million1.08% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.07MShares$16.8 Million0.03% of portfolio
-
Suvretta Capital Management, LLC New York, NY2.68MShares$14.6 Million0.52% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.51MShares$13.7 Million0.0% of portfolio
-
Western Standard LLC Los Angeles, CA2.09MShares$11.4 Million6.61% of portfolio
About ABEONA THERAPEUTICS INC.
- Ticker ABEO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 5,950,380
- Market Cap $32.5M
- Description
- Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-a...